A CELLULAR PROTEIN MEDIATES ASSOCIATION OF P53 WITH THE E6 ONCOPROTEIN OF HUMAN PAPILLOMAVIRUS TYPE-16 OR TYPE-18

被引:704
|
作者
HUIBREGTSE, JM
SCHEFFNER, M
HOWLEY, PM
机构
[1] Lab of Tumor Virus Biology, National Cancer Institute, Bethesda
来源
EMBO JOURNAL | 1991年 / 10卷 / 13期
关键词
HUMAN PAPILLOMAVIRUS; HPV E6; P53; UBIQUITIN-DEPENDENT PROTEOLYSIS; VIRAL ONCOPROTEIN;
D O I
10.1002/j.1460-2075.1991.tb04990.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The E6 protein of human papillomavirus types 16 and 18 (HPV-16 and HPV-18) can stably associate with the p53 protein in vitro. In the presence of rabbit reticulocyte lysate, this association leads to the specific degradation of p53 through the ubiquitin-dependent proteolysis system. We have examined the E6-p53 complex in more detail and have found that association of E6 with p53 is mediated by an additional cellular factor. This factor is present in rabbit reticulocyte lysate, primary human keratinocytes and in each of five human cell lines examined. The factor is designated E6-AP, for E6-associated protein, based on the observation that the E6 proteins of HPV-16 and 18 can form a stable complex with the factor in the absence of p53, whereas p53 association with the factor can be detected only in the presence of E6. Gel filtration and coprecipitation experiments indicate that E6-AP is a monomeric protein of approximately 100 kDa.
引用
收藏
页码:4129 / 4135
页数:7
相关论文
共 50 条
  • [1] ASSOCIATION OF HUMAN PAPILLOMAVIRUS TYPE-16 AND TYPE-18 E6 PROTEINS WITH P53
    WERNESS, BA
    LEVINE, AJ
    HOWLEY, PM
    SCIENCE, 1990, 248 (4951) : 76 - 79
  • [2] THE E6 ONCOPROTEIN ENCODED BY HUMAN PAPILLOMAVIRUS TYPE-16 AND TYPE-18 PROMOTES THE DEGRADATION OF P53
    SCHEFFNER, M
    WERNESS, BA
    HUIBREGTSE, JM
    LEVINE, AJ
    HOWLEY, PM
    CELL, 1990, 63 (06) : 1129 - 1136
  • [3] INTERACTION OF THE HUMAN PAPILLOMAVIRUS TYPE-16 E6 ONCOPROTEIN WITH WILD-TYPE AND MUTANT HUMAN P53 PROTEINS
    SCHEFFNER, M
    TAKAHASHI, T
    HUIBREGTSE, JM
    MINNA, JD
    HOWLEY, PM
    JOURNAL OF VIROLOGY, 1992, 66 (08) : 5100 - 5105
  • [4] IMMUNOLOGICAL DETECTION OF E6 REGION PROTEIN FROM HUMAN PAPILLOMAVIRUS TYPE-16 AND TYPE-18 IN PREMALIGNANT CERVICAL LESIONS
    GUIOT, MCP
    CAVENEE, WK
    BANKS, L
    CRAWFORD, L
    ARSENEAU, J
    MATLASHEWSKI, G
    MOLECULAR DIAGNOSTICS OF HUMAN CANCER, 1989, 7 : 193 - 196
  • [5] TARGETING AND DEGRADATION OF P53 BY E6 OF HUMAN PAPILLOMAVIRUS TYPE-16 IS PREFERENTIAL FOR THE 1620+ P53 CONFORMATION
    MEDCALF, EA
    MILNER, J
    ONCOGENE, 1993, 8 (10) : 2847 - 2851
  • [6] IMMUNOHISTOCHEMICAL DETECTION OF P53 IN CERVICAL EPITHELIAL LESIONS WITH OR WITHOUT INFECTION OF HUMAN PAPILLOMAVIRUS TYPE-16 AND TYPE-18
    AKASOFU, M
    ODA, Y
    VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY, 1995, 425 (06): : 593 - 602
  • [7] PROGNOSTIC-SIGNIFICANCE OF HUMAN PAPILLOMAVIRUS GENOMES (TYPE-16, TYPE-18) AND ABERRANT EXPRESSION OF P53 PROTEIN IN HUMAN ESOPHAGEAL CANCER
    FURIHATA, M
    OHTSUKI, Y
    OGOSHI, S
    TAKAHASHI, A
    TAMIYA, T
    OGATA, T
    INTERNATIONAL JOURNAL OF CANCER, 1993, 54 (02) : 226 - 230
  • [8] Degradation of p53 by natural variants of the E6 protein of human papillomavirus type 16
    Yi, Ja Woon
    Jang, Mi
    Kim, Sung Jin
    Kim, Sung Soon
    Rhee, Jee Eun
    ONCOLOGY REPORTS, 2013, 29 (04) : 1617 - 1622
  • [9] DNA-DAMAGE INDUCED P53 MEDIATED TRANSCRIPTION IS INHIBITED BY HUMAN PAPILLOMAVIRUS TYPE-18 E6
    GU, ZM
    PIM, D
    LABRECQUE, S
    BANKS, L
    MATLASHEWSKI, G
    ONCOGENE, 1994, 9 (02) : 629 - 633
  • [10] HUMAN PAPILLOMAVIRUS TYPE-16 AND TYPE-18 IN ADENOCARCINOMA OF THE UTERINE CERVIX
    LEMINEN, A
    PAAVONEN, J
    VESTERINEN, E
    WAHLSTROM, T
    RANTALA, I
    LEHTINEN, M
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1991, 95 (05) : 647 - 652